{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:26:13Z","timestamp":1794259573629,"version":"4.9.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Conseller\u00eda de Cultura, Educaci\u00f3n e Universidades de la Xunta de Galicia","award":["ED481B-2023-092"],"award-info":[{"award-number":["ED481B-2023-092"]}],"id":[{"id":"https:\/\/ror.org\/0181xnw06","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Conseller\u00eda de Cultura, Educaci\u00f3n e Universidades de la Xunta de Galicia","award":["ED481D-2024-011"],"award-info":[{"award-number":["ED481D-2024-011"]}],"id":[{"id":"https:\/\/ror.org\/0181xnw06","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010769","name":"Axencia Galega de Innovaci\u00f3n","doi-asserted-by":"publisher","award":["ED431C 2025\/08"],"award-info":[{"award-number":["ED431C 2025\/08"]}],"id":[{"id":"10.13039\/501100010769","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universidade de Santiago de Compostela","id":[{"id":"https:\/\/ror.org\/030eybx10","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Onychomycosis, a prevalent fungal infection, and psoriasis, a chronic immune disorder affecting the nail plate, present therapeutic challenges due to the limited efficacy of current treatments, often leading to prolonged therapy and a high relapse rate. The highly cross-linked keratin network of the nail plate acts as a barrier, impeding effective drug delivery. This pioneering study explores a novel approach using a tattoo device to enhance drug penetration through the nail. Ciclopirox olamine and clobetasol lacquers were selected as the model formulations. Drug permeation tests conducted on non-treated, filed (mechanically abraded), and tattooed nails demonstrated significantly higher drug permeation in tattooed nails, suggesting the potential of this delivery method. Nail tattooing offers a simple method to enhance topical therapy, allowing treatment initiation in the clinic and continuation at home.<\/jats:p>","DOI":"10.1007\/s13346-026-02102-z","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T18:34:05Z","timestamp":1774550045000},"page":"4293-4308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nail tattooing: a novel and minimally invasive technique for enhancing drug penetration through the nail"],"prefix":"10.1007","volume":"16","author":[{"given":"Carlos","family":"Bendicho-Lavilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"D\u00edaz-Tom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iria","family":"Seoane-Via\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius","family":"de-Monte-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Otero-Espinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"issue":"9","key":"2102_CR1","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1111\/jdv.16394","volume":"34","author":"AK Gupta","year":"2020","unstructured":"Gupta AK, Stec N, Summerbell RC, Shear NH, Piguet V, Tosti A, et al. Onychomycosis: a review. J Eur Acad Dermatol Venereol. 2020;34(9):1972\u201390. https:\/\/doi.org\/10.1111\/jdv.16394.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"2102_CR2","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.jaad.2018.05.1260","volume":"80","author":"SR Lipner","year":"2019","unstructured":"Lipner SR, Scher RK. Onychomycosis: treatment and prevention of recurrence. J Am Acad Dermatol. 2019;80(4):853\u201367. https:\/\/doi.org\/10.1016\/j.jaad.2018.05.1260.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2102_CR3","first-page":"379","volume":"10","author":"AK Gupta","year":"2000","unstructured":"Gupta AK, Humke S. The prevalence and management of onychomycosis in diabetic patients. Eur J Dermatol. 2000;10(5):379\u201384 (PubMed PMID: 10882947).","journal-title":"Eur J Dermatol"},{"issue":"2","key":"2102_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0891-8422(23)01050-9","volume":"15","author":"LJ Loveland","year":"1998","unstructured":"Loveland LJ. Onychomycosis in HIV-positive patients. Clin Podiatr Med Surg. 1998Apr;15(2):305\u201315 (PubMed PMID: 9576055).","journal-title":"Clin Podiatr Med Surg"},{"issue":"5","key":"2102_CR5","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s40257-019-00448-4","volume":"20","author":"C Daggett","year":"2019","unstructured":"Daggett C, Brodell RT, Daniel CR, Jackson J. Onychomycosis in athletes. Am J Clin Dermatol. 2019;20(5):691\u20138. https:\/\/doi.org\/10.1007\/s40257-019-00448-4.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"2102_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cpm.2016.02.001","volume":"33","author":"TC Vlahovic","year":"2016","unstructured":"Vlahovic TC. Onychomycosis: evaluation, treatment options, managing recurrence, and patient outcomes. Clin Podiatr Med Surg. 2016;33(3):305\u201318. https:\/\/doi.org\/10.1016\/j.cpm.2016.02.001.","journal-title":"Clin Podiatr Med Surg"},{"issue":"2","key":"2102_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/jdv.18638","volume":"37","author":"AK Gupta","year":"2023","unstructured":"Gupta AK, Polla Ravi S, Choi SY, Konda A, Cooper EA. Strategies for the enhancement of nail plate permeation of drugs to treat onychomycosis. J Eur Acad Dermatol Venereol. 2023;37(2):243\u201355. https:\/\/doi.org\/10.1111\/jdv.18638.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"2102_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s40257-020-00580-6","volume":"22","author":"AK Gupta","year":"2021","unstructured":"Gupta AK, Renaud HJ, Quinlan EM, Shear NH, Piguet V. The growing problem of antifungal resistance in onychomycosis and other superficial mycoses. Am J Clin Dermatol. 2021;22(2):149\u201357. https:\/\/doi.org\/10.1007\/s40257-020-00580-6.","journal-title":"Am J Clin Dermatol"},{"key":"2102_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jconrel.2015.10.026","volume":"220","author":"WS Chiu","year":"2015","unstructured":"Chiu WS, Belsey NA, Garrett NL, Moger J, Price GJ, Delgado-Charro MB, et al. Drug delivery into microneedle-porated nails from nanoparticle reservoirs. J Control Release. 2015;220:98\u2013106. https:\/\/doi.org\/10.1016\/j.jconrel.2015.10.026.","journal-title":"J Control Release"},{"issue":"1","key":"2102_CR10","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-020-00552-y","volume":"23","author":"K Chen","year":"2021","unstructured":"Chen K, Puri V, Michniak-Kohn B. Iontophoresis to overcome the challenge of nail permeation: considerations and optimizations for successful ungual drug delivery. AAPS J. 2021;23(1):25. https:\/\/doi.org\/10.1208\/s12248-020-00552-y.","journal-title":"AAPS J"},{"issue":"12","key":"2102_CR11","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.7863\/jum.2011.30.12.1723","volume":"30","author":"D Abadi","year":"2011","unstructured":"Abadi D, Zderic V. Ultrasound-mediated nail drug delivery system. J Ultrasound Med. 2011;30(12):1723\u201330. https:\/\/doi.org\/10.7863\/jum.2011.30.12.1723.","journal-title":"J Ultrasound Med"},{"key":"2102_CR12","doi-asserted-by":"publisher","first-page":"0000","DOI":"10.7547\/18-084","volume":"24","author":"A Kline-Schoder","year":"2019","unstructured":"Kline-Schoder A, Le Z, Sweeney L, Zderic V. Optimization of ultrasound-mediated drug delivery for treatment of onychomycosis. J Am Podiatr Med Assoc. 2019;24:0000\u20130000. https:\/\/doi.org\/10.7547\/18-084.","journal-title":"J Am Podiatr Med Assoc"},{"issue":"2","key":"2102_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14020448","volume":"14","author":"TD Pollard","year":"2022","unstructured":"Pollard TD, Bonetti M, Day A, Gaisford S, Orlu M, Basit AW, et al. Printing drugs onto nails for effective treatment of onychomycosis. Pharmaceutics. 2022;14(2):2. https:\/\/doi.org\/10.3390\/pharmaceutics14020448.","journal-title":"Pharmaceutics"},{"key":"2102_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jconrel.2017.10.014","volume":"268","author":"S Vanstone","year":"2017","unstructured":"Vanstone S, Cordery SF, Stone JM, Gordeev SN, Guy RH. Precise laser poration to control drug delivery into and through human nail. J Control Release. 2017;268:72\u20137. https:\/\/doi.org\/10.1016\/j.jconrel.2017.10.014.","journal-title":"J Control Release"},{"issue":"2","key":"2102_CR15","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-019-1591-9","volume":"21","author":"A Vikas","year":"2020","unstructured":"Vikas A, Rashmin P, Mrunali P, Chavan RB, Kaushik T. Mechanistic insights of formulation approaches for the treatment of nail infection: conventional and novel drug delivery approaches. AAPS PharmSciTech. 2020;21(2):67. https:\/\/doi.org\/10.1208\/s12249-019-1591-9.","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"2102_CR16","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-023-02603-x","volume":"24","author":"WH Abd-Elsalam","year":"2023","unstructured":"Abd-Elsalam WH, Abouelatta SM. Contemporary techniques and potential transungual drug delivery nanosystems for the treatment of onychomycosis. AAPS PharmSciTech. 2023;24(6):150. https:\/\/doi.org\/10.1208\/s12249-023-02603-x.","journal-title":"AAPS PharmSciTech"},{"issue":"14","key":"2102_CR17","doi-asserted-by":"publisher","DOI":"10.1063\/1.5074176","volume":"125","author":"L Oyarte G\u00e1lvez","year":"2019","unstructured":"Oyarte G\u00e1lvez L, Bri\u00f3 P\u00e9rez M, Fern\u00e1ndez Rivas D. High speed imaging of solid needle and liquid micro-jet injections. J Appl Phys. 2019;125(14):144504. https:\/\/doi.org\/10.1063\/1.5074176.","journal-title":"J Appl Phys"},{"key":"2102_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-1-4939-0410-5_9","volume":"1143","author":"JH van den Berg","year":"2014","unstructured":"van den Berg JH, Oosterhuis K, Schumacher TNM, Haanen JBAG, Bins AD. Intradermal vaccination by DNA tattooing. Methods Mol Biol. 2014;1143:131\u201340. https:\/\/doi.org\/10.1007\/978-1-4939-0410-5_9.","journal-title":"Methods Mol Biol"},{"issue":"3","key":"2102_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201700771","volume":"5","author":"LM Ferrari","year":"2018","unstructured":"Ferrari LM, Sudha S, Tarantino S, Esposti R, Bolzoni F, Cavallari P, et al. Ultraconformable temporary tattoo electrodes for electrophysiology. Adv Sci. 2018;5(3):1700771. https:\/\/doi.org\/10.1002\/advs.201700771.","journal-title":"Adv Sci"},{"issue":"3","key":"2102_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12030231","volume":"12","author":"E Cutr\u00edn-G\u00f3mez","year":"2020","unstructured":"Cutr\u00edn-G\u00f3mez E, Conde-Penedo A, Anguiano-Igea S, G\u00f3mez-Amoza JL, Otero-Espinar FJ. Optimization of drug permeation from 8% ciclopirox cyclodextrin\/poloxamer-soluble polypseudorotaxane-based nail lacquers. Pharmaceutics. 2020;12(3):3. https:\/\/doi.org\/10.3390\/pharmaceutics12030231.","journal-title":"Pharmaceutics"},{"issue":"8","key":"2102_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12080730","volume":"12","author":"F Fern\u00e1ndez-Campos","year":"2020","unstructured":"Fern\u00e1ndez-Campos F, Navarro F, Corrales A, Picas J, Pena E, Gonz\u00e1lez J, et al. Transungual delivery, anti-inflammatory activity, and in vivo assessment of a cyclodextrin polypseudorotaxanes nail lacquer. Pharmaceutics. 2020;12(8):8. https:\/\/doi.org\/10.3390\/pharmaceutics12080730.","journal-title":"Pharmaceutics"},{"key":"2102_CR22","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios C. Propecto DexULac\u00ae 80 mg\/g Barniz de U\u00f1as Medicamentoso [Internet]. [cited 2023 Sep 29]. Available from: https:\/\/cima.aemps.es\/cima\/dochtml\/p\/84423\/P_84423.html.\u00a0Accessed 29 Sept 2023."},{"issue":"1","key":"2102_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.2042-7158.1997.tb06747.x","volume":"49","author":"D Mertin","year":"1997","unstructured":"Mertin D, Lippold BC. In-vitro permeability of the human nail and of a keratin membrane from bovine hooves: influence of the partition coefficient octanol\/water and the water solubility of drugs on their permeability and maximum flux. J Pharm Pharmacol. 1997;49(1):30\u20134. https:\/\/doi.org\/10.1111\/j.2042-7158.1997.tb06747.x.","journal-title":"J Pharm Pharmacol"},{"issue":"9","key":"2102_CR24","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/j.2042-7158.1997.tb06127.x","volume":"49","author":"D Mertin","year":"1997","unstructured":"Mertin D, Lippold BC. In-vitro permeability of the human nail and of a keratin membrane from bovine hooves: prediction of the penetration rate of antimycotics through the nail plate and their efficacy. J Pharm Pharmacol. 1997;49(9):866\u201372. https:\/\/doi.org\/10.1111\/j.2042-7158.1997.tb06127.x.","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"2102_CR25","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jpba.2009.08.019","volume":"51","author":"W Bu","year":"2010","unstructured":"Bu W, Fan X, Sexton H, Heyman I. A direct LC\/MS\/MS method for the determination of ciclopirox penetration across human nail plate in in vitro penetration studies. J Pharm Biomed Anal. 2010;51(1):230\u20135. https:\/\/doi.org\/10.1016\/j.jpba.2009.08.019.","journal-title":"J Pharm Biomed Anal"},{"key":"2102_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2023.100181","volume":"5","author":"P Carou-Senra","year":"2023","unstructured":"Carou-Senra P, Ong JJ, Castro BM, Seoane-Via\u00f1o I, Rodr\u00edguez-Pombo L, Cabalar P, et al. Predicting pharmaceutical inkjet printing outcomes using machine learning. Int J Pharm X. 2023;5:100181. https:\/\/doi.org\/10.1016\/j.ijpx.2023.100181.","journal-title":"Int J Pharm X"},{"issue":"3","key":"2102_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/ijd.14198","volume":"58","author":"M Batory","year":"2019","unstructured":"Batory M, Namieci\u0144ski P, Rotsztejn H. Evaluation of structural damage and pH of nail plates of hands after applying different methods of decorating. Int J Dermatol. 2019;58(3):311\u20138. https:\/\/doi.org\/10.1111\/ijd.14198.","journal-title":"Int J Dermatol"},{"key":"2102_CR28","doi-asserted-by":"publisher","DOI":"10.1101\/2021.02.02.429454","author":"I Lawal","year":"2021","unstructured":"Lawal I, Rohilla P, Marston J. Drug delivery via tattooing: effect of needle and fluid properties. bioRxiv. 2021. https:\/\/doi.org\/10.1101\/2021.02.02.429454.","journal-title":"bioRxiv"},{"key":"2102_CR29","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ejps.2019.02.014","volume":"131","author":"F Laub\u00e9","year":"2019","unstructured":"Laub\u00e9 F, Poupon A, Zinck P, M\u00fcller-Goymann C, Reichl S, Nardello-Rataj V. Physicochemical investigations of native nails and synthetic models for a better understanding of surface adhesion of nail lacquers. Eur J Pharm Sci. 2019;131:208\u201317. https:\/\/doi.org\/10.1016\/j.ejps.2019.02.014.","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"2102_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10040273","volume":"10","author":"E Cutr\u00edn-G\u00f3mez","year":"2018","unstructured":"Cutr\u00edn-G\u00f3mez E, Anguiano-Igea S, Delgado-Charro MB, G\u00f3mez-Amoza JL, Otero-Espinar FJ. Effect of penetration enhancers on drug nail permeability from cyclodextrin\/poloxamer-soluble polypseudorotaxane-based nail lacquers. Pharmaceutics. 2018;10(4):273. https:\/\/doi.org\/10.3390\/pharmaceutics10040273.","journal-title":"Pharmaceutics"},{"issue":"1","key":"2102_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-5173(01)00989-9","volume":"236","author":"S Murdan","year":"2002","unstructured":"Murdan S. Drug delivery to the nail following topical application. Int J Pharm. 2002;236(1):1\u201326. https:\/\/doi.org\/10.1016\/S0378-5173(01)00989-9.","journal-title":"Int J Pharm"},{"key":"2102_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124012","volume":"656","author":"M Miranda","year":"2024","unstructured":"Miranda M, Volmer Z, Cornick A, Goody A, Cardoso C, Pais AACC, et al. In vitro studies into establishing therapeutic bioequivalence of complex topical products: weight of evidence. Int J Pharm. 2024;656:124012. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124012.","journal-title":"Int J Pharm"},{"issue":"2","key":"2102_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26020280","volume":"26","author":"AE Chiriac","year":"2021","unstructured":"Chiriac AE, Azoicai D, Coroaba A, Doroftei F, Timpu D, Chiriac A, et al. Raman spectroscopy, X-ray diffraction, and scanning electron microscopy as noninvasive methods for microstructural alterations in psoriatic nails. Molecules. 2021;26(2):2. https:\/\/doi.org\/10.3390\/molecules26020280.","journal-title":"Molecules"},{"key":"2102_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejpb.2018.04.012","volume":"128","author":"E Cutr\u00edn G\u00f3mez","year":"2018","unstructured":"Cutr\u00edn G\u00f3mez E, Anguiano Igea S, Delgado-Charro MB, G\u00f3mez Amoza JL, Otero Espinar FJ. Microstructural alterations in the onychomycotic and psoriatic nail: relevance in drug delivery. Eur J Pharm Biopharm. 2018;128:48\u201356. https:\/\/doi.org\/10.1016\/j.ejpb.2018.04.012.","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"2102_CR35","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1007\/s11095-014-1562-5","volume":"32","author":"A Baraldi","year":"2015","unstructured":"Baraldi A, Jones SA, Guesn\u00e9 S, Traynor MJ, McAuley WJ, Brown MB, et al. Human nail plate modifications induced by onychomycosis: implications for topical therapy. Pharm Res. 2015;32(5):1626\u201333. https:\/\/doi.org\/10.1007\/s11095-014-1562-5.","journal-title":"Pharm Res"},{"issue":"7","key":"2102_CR36","doi-asserted-by":"publisher","first-page":"6851","DOI":"10.1021\/acsnano.8b02099","volume":"12","author":"F Wang","year":"2018","unstructured":"Wang F, Yang P, Choi J, Antovski P, Zhu Y, Xu X, et al. Cross-linked fluorescent supramolecular nanoparticles for intradermal controlled release of antifungal drug\u2014a therapeutic approach for onychomycosis. ACS Nano. 2018;12(7):6851\u20139. https:\/\/doi.org\/10.1021\/acsnano.8b02099.","journal-title":"ACS Nano"},{"issue":"1","key":"2102_CR37","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ijpharm.2016.08.025","volume":"514","author":"LV Kerai","year":"2016","unstructured":"Kerai LV, Hilton S, Maugueret M, Kazi BB, Faull J, Bhakta S, et al. UV-curable gels as topical nail medicines:In vivo residence, anti-fungal efficacy and influence of gel components on their properties. Int J Pharm. 2016;514(1):244\u201354. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.08.025.","journal-title":"Int J Pharm"},{"key":"2102_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121437","volume":"614","author":"K Rizi","year":"2022","unstructured":"Rizi K, Xu K, Begum T, Faull J, Bhakta S, Murdan S. A drug-in-adhesive anti-onychomycotic nail patch: influence of drug and adhesive nature on drug release, ungual permeation, in vivo residence in human and anti-fungal efficacy. Int J Pharm. 2022;614:121437. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121437.","journal-title":"Int J Pharm"},{"key":"2102_CR39","unstructured":"Directive 2001\/95\/EC of the European Parliament and of the Council of 3 December 2001 on general product safety (Text with EEA relevance) [Internet]. 2010 Jan 1. Available from: http:\/\/data.europa.eu\/eli\/dir\/2001\/95\/2010-01-01\/eng.\u00a0Accessed 2 Mar 2024."},{"key":"2102_CR40","unstructured":"Parliamentary question | Answer to Question No E-013827\/13 | E-013827\/2013(ASW) | European Parliament [Internet]. [cited 2023 Oct 6]. Available from: https:\/\/www.europarl.europa.eu\/doceo\/document\/E-7-2013-013827-ASW_EN.html.\u00a0Accessed 6 Oct 2023."},{"key":"2102_CR41","unstructured":"Nutrition C for FS and A. FDA [Internet]. FDA; 2023 [cited 2023 Oct 6]. Modernization of Cosmetics Regulation Act of 2022. Available from: https:\/\/www.fda.gov\/cosmetics\/cosmetics-laws-regulations\/modernization-cosmetics-regulation-act-2022-mocra. Accessed 13 Mar 2026."},{"issue":"0","key":"2102_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13543776.2023.2268278","volume":"0","author":"S Chakraborty","year":"2023","unstructured":"Chakraborty S, Sanshita N, Singh I. Therapeutic treatment strategies for the management of onychomycosis: a patent perspective. Expert Opin Ther Pat. 2023;0(0):1\u201318. https:\/\/doi.org\/10.1080\/13543776.2023.2268278.","journal-title":"Expert Opin Ther Pat"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02102-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02102-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02102-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:53:22Z","timestamp":1794257602000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02102-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2102"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02102-z","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by Santiago-Lugo Research Ethics Committee (Project identification code: 2018\/099, Date of approval: 22 February 2018) and was conducted in accordance with the ethical principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants prior to their inclusion in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval and written informed consent to participate were obtained as described below.","order":3,"name":"Ethics","label":"Human ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No gels or blots were generated or used in this study; therefore, uncropped gel or blot images are not applicable.","order":4,"name":"Ethics","label":"Supplementary Information","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}